Galera Therapeutics, Inc. announced a 1-for-200 reverse stock split of its common stock, which is expected to become effective on July 12, 2026. The split will automatically convert every two hundred shares into one share and will also adjust the exercise prices of outstanding stock options and warrants. Galera Therapeutics, Inc. is a biotechnology company focused on developing medical cannabis-based therapies.
